Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Apr;15(2):147-148.
doi: 10.5217/ir.2017.15.2.147. Epub 2017 Apr 27.

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

Jong Pil Im  1
Affiliations
Editorial

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

Jong Pil Im. Intest Res. 2017 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None.

Comment on

  • Intest Res. 15:182.

References

    1. Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14:111–119. - PMC - PubMed
    1. Lee HA, Suk JY, Choi SY, et al. Characteristics of pediatric inflammatory bowel disease in Korea: comparison with EUROKIDS data. Gut Liver. 2015;9:756–760. - PMC - PubMed
    1. Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. Gut. 2014;63:1381–1392. - PubMed
    1. Park JJ, Yang SK, Ye BD, et al. Second Korean guidelines for the management of Crohn's disease. Intest Res. 2017;15:38–67. - PMC - PubMed
    1. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340:1398–1405. - PubMed

Publication types

LinkOut - more resources